TransMedics (TMDX) Cash from Operations (2018 - 2026)

TransMedics' Cash from Operations history runs 9 years deep, the most recent figure standing at 24533000.0 for Q1 2026.

• On a quarterly basis, Cash from Operations rose 959.3% year-over-year to 24533000.0 in Q1 2026; TTM through Mar 2026 was 220228000.0, a 345.96% increase from a year earlier, with the FY2025 full-year figure at 192840000.0, up 295.14% from the prior year.
• Cash from Operations slipped to 24533000.0 in Q1 2026 per TMDX's latest filing, from 34513000.0 in the prior quarter.
• Across five years, Cash from Operations topped out at 91609000.0 in Q2 2025 and bottomed at 18406000.0 in Q1 2022.
• The 5-year median for Cash from Operations is 2855000.0 (2025), against an average of 12195941.18.
• Across the five-year window, Cash from Operations plunged 151.11% in 2022 and soared 959.3% in 2026, its largest moves.
• Year by year, Cash from Operations stood at 4035000.0 in 2022, then soared by 305.8% to 8304000.0 in 2023, then soared by 136.79% to 19663000.0 in 2024, then jumped by 75.52% to 34513000.0 in 2025, then retreated by 28.92% to 24533000.0 in 2026.
• Per Business Quant, the three latest TMDX Cash from Operations figures stand at 24533000.0 (Q1 2026), 34513000.0 (Q4 2025), and 69573000.0 (Q3 2025).